-
1
-
-
45849116513
-
-
Xia, M.; Knezevic, D.; Tovar, C.; Huang, B.; Heimbrook, D. C.; Vassilev, L. Cell Cycle 2008, 7, 1604
-
(2008)
Cell Cycle
, vol.7
, pp. 1604
-
-
Xia, M.1
Knezevic, D.2
Tovar, C.3
Huang, B.4
Heimbrook, D.C.5
Vassilev, L.6
-
4
-
-
10744221485
-
-
Vassilev, L. T.; Vu, B. T.; Graves, B.; Cavajal, D.; Podlaski, F.; Filipovic, Z.; Kong, N.; Kammlott, U.; Lukacs, C.; Klein, C.; Fotouhi, N.; Liu, E. A. Science 2004, 303, 844
-
(2004)
Science
, vol.303
, pp. 844
-
-
Vassilev, L.T.1
Vu, B.T.2
Graves, B.3
Cavajal, D.4
Podlaski, F.5
Filipovic, Z.6
Kong, N.7
Kammlott, U.8
Lukacs, C.9
Klein, C.10
Fotouhi, N.11
Liu, E.A.12
-
5
-
-
84867799715
-
-
PCT Int. Appl. WO 2007063013, 2007; CAN 147:52890.
-
Ding, Q.; Graves, B. J.; Kong, N.; Liu, J.; Lovey, A. J.; Pizzolato, G.; Roberts, J. L.; So, S.; Vu, B. T.; Wovkulich, P. M. 2,4,5-Triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents. PCT Int. Appl. WO 2007063013, 2007; CAN 147:52890.
-
2,4,5-Triphenyl Imidazoline Derivatives As Inhibitors of the Interaction between p53 and MDM2 Proteins for Use As Anticancer Agents
-
-
Ding, Q.1
Graves, B.J.2
Kong, N.3
Liu, J.4
Lovey, A.J.5
Pizzolato, G.6
Roberts, J.L.7
So, S.8
Vu, B.T.9
Wovkulich, P.M.10
-
7
-
-
77953702026
-
-
Azmi, A. S.; Philip, P. A.; Almhanna, K.; Beck, F. W.; Kafri, Z. K.; Sarkar, F. H.; Mohammad, R. M. Mini-Rev. Med. Chem. 2010, 10, 518
-
(2010)
Mini-Rev. Med. Chem.
, vol.10
, pp. 518
-
-
Azmi, A.S.1
Philip, P.A.2
Almhanna, K.3
Beck, F.W.4
Kafri, Z.K.5
Sarkar, F.H.6
Mohammad, R.M.7
-
8
-
-
84862856894
-
-
In; Aktories, K. Compas, R. W. Cooper, M. D. Gleba, Y. Y. Honjo, T. Koprowski, H. Malissen, B. Melchers, F. Oldstone, M. B. A. Olsnes, S. Vogt, P. K. Current Topics in Microbiology and Immunology; Springer-Verlag: Berlin, Germany, Vol.
-
Vassilev, L.; Fry, D. In Small-Molecule Inhibitors of Protein-Protein Interactions; Aktories, K.; Compas, R. W.; Cooper, M. D.; Gleba, Y. Y.; Honjo, T.; Koprowski, H.; Malissen, B.; Melchers, F.; Oldstone, M. B. A.; Olsnes, S.; Vogt, P. K., Eds.; Current Topics in Microbiology and Immunology; Springer-Verlag: Berlin, Germany, 2011; Vol. 348, pp 151-172.
-
(2011)
Small-Molecule Inhibitors of Protein-Protein Interactions
, vol.348
, pp. 151-172
-
-
Vassilev, L.1
Fry, D.2
-
10
-
-
0034555135
-
-
Pasquato, L.; Modena, G.; Cotarca, L.; Delogu, P.; Mantovani, S. J. Org. Chem. 2000, 65, 8224
-
(2000)
J. Org. Chem.
, vol.65
, pp. 8224
-
-
Pasquato, L.1
Modena, G.2
Cotarca, L.3
Delogu, P.4
Mantovani, S.5
-
11
-
-
81555198244
-
-
Presented at The 5th International Conference and Exhibition on Process Analytical Technologies (PAT) In Organic Process R&D, Clearwater, FL.
-
Williamson, R. T. Recent PAT Applications at Roche Carolina, Inc.; Adventures with Phosgene and Beyond. Presented at The 5th International Conference and Exhibition on Process Analytical Technologies (PAT) In Organic Process R&D, Clearwater, FL, 2010.
-
(2010)
Recent Pat Applications at Roche Carolina, Inc.; Adventures with Phosgene and beyond
-
-
Williamson, R.T.1
-
13
-
-
0025293850
-
-
Bermudez, J.; Dabbs, S.; Joiner, K. A.; King, F. D. J. Med. Chem. 1990, 33, 1929
-
(1990)
J. Med. Chem.
, vol.33
, pp. 1929
-
-
Bermudez, J.1
Dabbs, S.2
Joiner, K.A.3
King, F.D.4
-
14
-
-
79952794360
-
-
U.S. Pat. Appl. US 20070037853, 2007; CAN 146:251846.
-
Barsanti, P. A.; Xia, Y.; Wang, W.; Mendenhall, K. G.; Lagniton, L. M.; Ramurthy, S.; Phillips, M. C.; Subramanian, S.; Boyce, R.; Brammeier, N. M.; Constantine, R.; Duhl, D.; Walter, A. O.; Abrams, T. J.; Renhowe, P. A. Substituted imidazole compounds as KSP inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancers. U.S. Pat. Appl. US 20070037853, 2007; CAN 146:251846.
-
Substituted Imidazole Compounds As KSP Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Cancers
-
-
Barsanti, P.A.1
Xia, Y.2
Wang, W.3
Mendenhall, K.G.4
Lagniton, L.M.5
Ramurthy, S.6
Phillips, M.C.7
Subramanian, S.8
Boyce, R.9
Brammeier, N.M.10
Constantine, R.11
Duhl, D.12
Walter, A.O.13
Abrams, T.J.14
Renhowe, P.A.15
-
15
-
-
81555211569
-
-
PCT Int. Appl. WO 2008144483, 2008; CAN 150:5777.
-
Gao, H.; Belvedere, S.; Webb, Y.; Landry, D.; Deng, S.; Cheng, Z.; Yan, J. Preparation of benzoxazepines, benzodiazepines, and benzazepines derivatives as agents for treating disorders involving modulation of ryanodine receptors. PCT Int. Appl. WO 2008144483, 2008; CAN 150:5777.
-
Preparation of Benzoxazepines, Benzodiazepines, and Benzazepines Derivatives As Agents for Treating Disorders Involving Modulation of Ryanodine Receptors
-
-
Gao, H.1
Belvedere, S.2
Webb, Y.3
Landry, D.4
Deng, S.5
Cheng, Z.6
Yan, J.7
-
16
-
-
81555213298
-
-
This byproduct was produced in 10 to 20 area % based on HPLC data. Characterization by LCMS was hindered by the instability of this compound. Attempts to react this byproduct with piperazine 6 to produce rac 8 under the reaction conditions were unsuccessful.
-
This byproduct was produced in 10 to 20 area % based on HPLC data. Characterization by LCMS was hindered by the instability of this compound. Attempts to react this byproduct with piperazine 6 to produce rac 8 under the reaction conditions were unsuccessful.
-
-
-
-
17
-
-
38149047965
-
-
1H NMR, refer to
-
1H NMR, refer to: Koyano, K.; Suzuki, H.; McArthur, C. R. Bull. Chem. Soc. Jpn. 1977, 50, 1872
-
(1977)
Bull. Chem. Soc. Jpn.
, vol.50
, pp. 1872
-
-
Koyano, K.1
Suzuki, H.2
McArthur, C.R.3
-
19
-
-
33645545062
-
-
Black, S. N.; Quigley, K.; Parker, A. Org. Process Res. Dev. 2006, 10, 241
-
(2006)
Org. Process Res. Dev.
, vol.10
, pp. 241
-
-
Black, S.N.1
Quigley, K.2
Parker, A.3
-
20
-
-
81555213299
-
-
The unit was equipped with a D600L Probe (diameter: 19 mm, length: 400 mm) constructed from Alloy C-276 with Kalrez seals.
-
The unit was equipped with a D600L Probe (diameter: 19 mm, length: 400 mm) constructed from Alloy C-276 with Kalrez seals.
-
-
-
|